NEW PRODUCT REPORT
JENVIS DRY EYE REPORT FOR OCULUS KERATOGRAPH
1 Developed for the Oculus Keratograph, the Jenvis Dry Eye Report assists in diagnosing dry eye. The report collects and summarizes data from a questionnaire, a slit lamp measurement of lid parallel conjunctival folds and four measurements performed with the Oculus Keratograph 5M, according to Oculus. These create an analysis of bulbar redness, measurements of tear meniscus height, tear film break-up time, and a meibography. Other screening methods, such as eye blink frequency or lipid layer analysis, also run on, and can be added to, the KeratogM.
Oculus
www.oculususa.com
RIGHTEYE NEURO VISION
2 The RightEye Neuro Vision is an eye-tracking digital concussion test that can be performed in 15 seconds. It is based on the smooth pursuit protocol, a leading manual concussion test widely used by physicians to determine if a person’s eyes can closely follow a moving object. To perform the test, a patient sits in front of a computer that has a small eye tracking bar beneath the screen and watches a circular digital animation for 15 seconds, according to the company.
RightEye
www.righteye.com
ZIEMER FEMTO LDV Z8
3 The FDA has granted approval for the Ziemer FEMTO LDV Z8, a mobile femtosecond laser for refractive, cornea and cataract procedures. An all-in-one system, the LDV Z8’s unique technology provides precision in the cornea and power in the lens through adjustable pulse energy, combined with a
high repetition rate to increase precision, according to Ziemer. The LDV Z8 is approved for Z-Lasik, Z-Lasik Z, intracorneal rings, intrastromal pockets, lamellar keraptoplasty, penetrating keratoplasty, anterior capsulotomy, lens fragmentation, clear corneal and arc incisions.
Ziemer USA
www.ziemerusa.com
NPR in brief
■ Ocular Therapeutix began patient enrollment for its third, phase 3 clinical trial for Dextenza. Designed for the treatment of post-surgical ocular pain, Dextenza is sustained release dexamethasone, placed through the punctum and into the canaliculus. A new drug application was filed with the FDA in late September. Trial results are expected late 2016.
■ Blanchard Contact Lenses announced design enhancements for its Onefit scleral lens. The design allows fitting for a wide range of applications, including normal prolate corneas, astigmatism, mild to moderate irregular corneas and multifocal and oblate corneas.
■ Plus power lenses for hyperopic patients are now available from Alcon’s Dailies Total 1 line of water-gradient contact lenses. The plus power lenses will be available in the United States this month, the company says. The lenses are available with a power range of -0.50 D to -6.00 D, in steps of 0.25; -6.50 D to -10.00 D, in 0.50 steps; and soon will be available in plus powers from +0.50 to +6.00, in 0.25 D steps. OM
![]({"src":"/media/ggydo1cw/112015.jpg","focalPoint":null,"crops":[{"alias":"thumbnail","width":1110,"height":700,"coordinates":null}]})